DEBORAH CAPSHAW: Open Payments
NPI 1295186203 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 29 payments from 14 companies in 2025. Trend: 2023 $380 · 2024 $2,837 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Novo Nordisk Inc | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| PFIZER INC. | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $31 |
| Boston Scientific Corporation | 1 | $27 |
Products named: ELIQUIS, LEQVIO, JARDIANCE, Wegovy, AMVUTTRA, REPATHA, JOT DX, WATCHMAN FLX.
Industry payments across MO — which companies pay providers there.
